Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Technique
- Analyzed With
- Chemical Group
- Compounds
- Detection Technique
- Injection Technique
- Instrument
- Analysis Platform
- Language
- Publication Date
1 - 20 of 30 results
Applied Filters
This Application Note describes a routine analysis workflow for pharmaceutical QA/QC labs.
| Korean (Korea) | Complete (PDF) |
|---|
必威体育登录手机Agilent 1260 Infinity II Prime LC with ISET – emulation of the Agilent 1200 Series Quaternary LC for analysis of antihistaminic drugs.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
In this application note, paracetamol is purified from an example crude sample using the 1290 Infinity II Preparative LC/MSD System.
必威体育登录手机Demonstrates simple and fast sample submission with the Agilent InfinityLab LC/MSD iQ for multiple users utilizing the sample purity workflow in an open-access environment.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Analysis of Brand versus Generic Medication Using the LC/MSD iQ for Mass Confirmation
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Russian (Russia) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |
必威体育登录手机Using the Agilent LC/MSD XT and Agilent InfinityLab Poroshell 120 HILIC-Z column for sensitive and reliable detection of delfampridine impurities
必威体育登录手机Presents a method for lipid identification from liposomal formulations using an Agilent 1290 Infinity II ELSD with a 1260 Infinity II LC.
Easy access chiral supercritical fluid chromatography (SFC) method development system for non‑chromatographers, to attain chiral SFC method development requirements.
必威体育登录手机Method development of chiral screening with the Agilent 1260 Infinity II SFC/UHPLC Hybrid System and selected Agilent InfinityLab Poroshell 120 chiral columns.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
必威体育登录手机Describes the use of the Agilent ChemStation Method Scouting Wizard in method development to separate and detect active compounds using SFC and TOF MS.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Korean (Korea) | Complete (PDF) |
| Portuguese (Brazil) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |
必威体育登录手机A demonstration of the straightforward analytical method transfer from the Waters Alliance 2695 LC to an Agilent 1260 Infinity II Prime LC by using ISET.
2D-LC/MS/MS analysis of drugs and their metabolites in a pharmacokinetic study, eliminating coelution and the risk of cross-talk for for a complex sample
| Korean (Korea) | Complete (PDF) |
|---|
必威体育登录手机Software-assisted development of SFC and UHPLC methods using the Agilent 1260 Infinity II SFC/UHPLC Hybrid System.
必威体育登录手机Development of a chiral separation method on the Agilent 1260 Infinity II Analytical SFC system using the Agilent ChemStation Method Scouting Wizard
必威体育登录手机Using the Agilent LC/MSD XT in open access mode provides tremendous user flexibility to automate compound confirmation and purity/impurity analysis
必威体育登录手机Workflow on QbD based UHPLC method development followed by method transfer to HPLC using ISET enabled Agilent 1290 Infinity II LC controlled by Waters Empower 3 CDS.
必威体育登录手机Universal method development for various HPLC systems using the Agilent 1290 Infinity II Method Development Solution with Intelligent System Emulation Technology
必威体育登录手机Small –scale purification of a monoclonal antibody from a cell lysate and the subsequent analysis on a single instrument, the Agilent 1260 Infinity Bio-inert Quaternary LC.
| Publication Part Number | 5991-1195EN | ||||
|---|---|---|---|---|---|
| Analysis | Analysed with Part No. |
|
|||
| Instrument |
|
||||
| Analytical Technique | Technique |
|
|||
| Injection |
|
||||
| Detection |
|
||||
| Sample | Chemical Group |
|
|||
| 示例矩陣 |
|
必威体育登录手机Method transfer from an Agilent 1100 Series LC to an Agilent 1290 Infinity II LC with ISET, while controlled through Waters Empower software.
QbD based method development and seemless transfer of UHPLC method to HPLC method using ISET under QbD principles.